The delay, narrowed approval, and extra study steps raise concerns about the status of and potential added requirements for other COVID vaccines.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Wide-ranging individual infectiousness challenges the notion that behavior is the main superspreader driver.
South African officials say they will have a clearer picture as next week unfolds, and officials in China's Guangdong province track an outbreak in the capital.
Cases are rising in South Africa, where researchers are closely tracking two new Omicron subvariants, BA.4 and BA.5. Both seem to be more transmissible than BA.2.
Risk factors for severe COVID varied by age, with BMI and underlying conditions more notable for younger adult patients and lab results more predictive for older people.
Using excess mortality data collected by the Centers for Disease Control and Prevention (CDC), researchers from Georgetown University found significant regional differences in mortality rates due to COVID-19, with a disproportionate number of virus deaths in Southern states.
Researchers detail new findings on long COVID risk, plus a promising role for occupational therapy to help cope with symptoms.
With deaths at the lowest point in about 2 years and cases declining, the WHO urged countries to keep a close eye on cases and virus changes.
Following the reappearance of Ebola in the Democratic Republic of the Congo's (DRC's) Equateur province, the country today launched an rVSV-EBOV vaccine campaign, tapping an initial shipment of 200 doses, the World Health Organization (WHO) African regional office said today.
The roadmap "will provide a framework for the development of broadly protective coronavirus vaccines to ensure that we are prepared to respond" to future SARS-CoV-2 variants or other viruses with pandemic potential.
Also, federal officials are taking steps to make sure Pfizer's COVID-19 pill, Paxlovid, will be widely available across the US.
